ATE500505T1 - Enzymhemmungsimmunverfahren - Google Patents

Enzymhemmungsimmunverfahren

Info

Publication number: ATE500505T1
Authority: AT; Austria
Prior art keywords: enzyme inhibition; analyte; inhibition immune; present; immune procedure
Prior art date: 2003-01-14

Inventor

Mitali Ghoshal

Gerald Sigler

Raymond A Hui

Ronald Hawley

Eva Hoess

Erasmus J Huber

John W Patterson

Salvatore J Salamone

Allan Dorn

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-01-14

Filing date

2004-01-09

Publication date

2011-03-15

2004-01-09Application filed by Hoffmann La RochefiledCriticalHoffmann La Roche

2011-03-15Application grantedgrantedCritical

2011-03-15Publication of ATE500505T1publicationCriticalpatent/ATE500505T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
- C07J19/005—Glycosides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
- G01N33/5735—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes co-enzymes or co-factors, e.g. NAD, ATP
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9453—Cardioregulators, e.g. antihypotensives, antiarrhythmics
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/904—Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Physics & Mathematics (AREA)
General Physics & Mathematics (AREA)
Microbiology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Pathology (AREA)
Analytical Chemistry (AREA)
Cell Biology (AREA)
Genetics & Genomics (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmacology & Pharmacy (AREA)
Cardiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Steroid Compounds (AREA)
Saccharide Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AT04000298T2003-01-142004-01-09EnzymhemmungsimmunverfahrenATE500505T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10/341,692US6811998B2 (en)	1999-06-25	2003-01-14	Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase

Publications (1)

Publication Number	Publication Date
ATE500505T1true ATE500505T1 (de)	2011-03-15

Family

ID=32594824

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04000298TATE500505T1 (de)	2003-01-14	2004-01-09	Enzymhemmungsimmunverfahren

Country Status (7)

Country	Link
US (3)	US6811998B2 (de)
EP (1)	EP1441224B1 (de)
JP (2)	JP4184986B2 (de)
AT (1)	ATE500505T1 (de)
CA (1)	CA2455097C (de)
DE (1)	DE602004031571D1 (de)
ES (1)	ES2360699T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6811998B2 (en)*	1999-06-25	2004-11-02	Roche Diagnostics Operations, Inc.	Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase
US7724740B1 (en)*	2002-08-27	2010-05-25	3Com Corporation	Computer system and network interface supporting class of service queues
US20050164330A1 (en)*	2004-01-27	2005-07-28	Daiichi Pure Chemicals Co., Ltd.	Method for quantitatively determining a specific component in a biological specimen, and reagent for quantitative determination
US20090215993A1 (en)*	2007-11-14	2009-08-27	Mitali Ghoshal	Mycophenolic acid immunogens and antibodies
CN105849117B (zh)	2013-08-29	2017-12-12	耶达研究及发展有限公司	Na,K‑ATP酶的α2亚型的选择性抑制剂和用于降低眼内压的用途
US10668094B2 (en)	2015-07-19	2020-06-02	Yeda Research And Development Co. Ltd.	Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure
WO2017013637A1 (en)*	2015-07-19	2017-01-26	Yeda Research And Development Co. Ltd.	Selective inhibitors of alpha2-containing isoforms of na,k-atpase and use thereof for reduction of intraocular pressure
EP3421050A1 (de)*	2017-06-30	2019-01-02	Helmholtz-Zentrum für Infektionsforschung GmbH	Aminoglykosidderivate und nano-anordnungen davon, einschliesslich solchen mit quorum-sensing-hemmender funktion

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1595101A (en)	1925-07-01	1926-08-10	American Assembling Machine Co	Method of and machine for assembling signatures
US4134792A (en)*	1976-12-06	1979-01-16	Miles Laboratories, Inc.	Specific binding assay with an enzyme modulator as a labeling substance
GB1595101A (en)	1977-03-15	1981-08-05	Hoffmann La Roche	Enzyme modifier immunoassay
US4273866A (en)	1979-02-05	1981-06-16	Abbott Laboratories	Ligand analog-irreversible enzyme inhibitor conjugates and methods for use
US4341865A (en)	1980-07-21	1982-07-27	Abbott Laboratories	Determination of thyroxine binding globulin
US4510251A (en)	1982-11-08	1985-04-09	Abbott Laboratories	Fluorescent polarization assay for ligands using aminomethylfluorescein derivatives as tracers
US5665583A (en)	1988-08-12	1997-09-09	Arch Dev Corp	Methods and materials relating to IMPDH and GMP production
DE69030829T2 (de)	1989-03-10	1998-01-15	Hoffmann La Roche	Reagenzien zum Nachweis von Drogen
US5352803A (en)	1992-03-30	1994-10-04	Abbott Laboratories	5(6)-methyl substituted fluorescein derivatives
US5283257A (en)	1992-07-10	1994-02-01	The Board Of Trustees Of The Leland Stanford Junior University	Method of treating hyperproliferative vascular disease
WO1994012184A1 (en)	1992-11-24	1994-06-09	Syntex (U.S.A.) Inc.	Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
US5512568A (en)	1994-02-18	1996-04-30	Syntex (U.S.A.) Inc.	Method of using 4-amino derivatives of 5-substituted mycophenolic acid
US5493030A (en)	1994-02-18	1996-02-20	Syntex (U.S.A.) Inc.	5-substituted derivatives of mycophenolic acid
US5444072A (en)	1994-02-18	1995-08-22	Syntex (U.S.A.) Inc.	6-substituted mycophenolic acid and derivatives
US5380879A (en)	1994-02-18	1995-01-10	Syntex (U.S.A.) Inc.	Derivatives of mycophenolic acid
US5525602A (en)	1994-02-18	1996-06-11	Syntex (U.S.A.) Inc.	Method of using 4-amino 6-substituted mycophenolic acid and derivatives
US6225073B1 (en)	1994-07-07	2001-05-01	Dade Behring Marburg Gmbh	Immunoassay for mycophenolic acid
US5756771A (en)	1995-04-13	1998-05-26	Abbott Laboratories	5(6)-methyl substituted fluorescein derivatives
US5807876A (en)	1996-04-23	1998-09-15	Vertex Pharmaceuticals Incorporated	Inhibitors of IMPDH enzyme
US6128582A (en)	1996-04-30	2000-10-03	Vertex Pharmaceuticals Incorporated	Molecules comprising an IMPDH-like binding pocket and encoded data storage medium capable of graphically displaying them
US6153398A (en)	1997-12-24	2000-11-28	The University Of Chicago	Method to identify specific inhibitors of IMP dehydrogenase
AU764479B2 (en)*	1998-10-29	2003-08-21	Bristol-Myers Squibb Company	Compounds derived from an amine nucleus that are inhibitors of IMPDH enzyme
US6420403B1 (en)*	1998-10-29	2002-07-16	Edwin J. Iwanowicz	Inhibitors of IMPDH enzyme
JP2000310638A (ja)*	1999-04-28	2000-11-07	Fuji Photo Film Co Ltd	均一系酵素免疫分析方法
US6107052A (en)*	1999-06-09	2000-08-22	Roche Diagnostics Corporation	Enzymatic measurement of mycophenolic acid
ES2298146T3 (es)*	1999-06-25	2008-05-16	Roche Diagnostics Operations, Inc.	Inmunoensayo de inhibicion de enzimas.
US6524808B1 (en)*	1999-06-25	2003-02-25	Roche Diagnostics Corporation	Enzyme inhibition immunoassay
US6811998B2 (en)*	1999-06-25	2004-11-02	Roche Diagnostics Operations, Inc.	Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase
EP1207394B1 (de)*	2000-11-14	2009-12-30	Roche Diagnostics GmbH	Immunoassay für HIV-Protease-Hemstoffe

2003
- 2003-01-14USUS10/341,692patent/US6811998B2/ennot_activeExpired - Fee Related
2004
- 2004-01-09DEDE602004031571Tpatent/DE602004031571D1/denot_activeExpired - Lifetime
- 2004-01-09ATAT04000298Tpatent/ATE500505T1/deactive
- 2004-01-09EPEP04000298Apatent/EP1441224B1/denot_activeExpired - Lifetime
- 2004-01-09JPJP2004004171Apatent/JP4184986B2/janot_activeExpired - Fee Related
- 2004-01-09ESES04000298Tpatent/ES2360699T3/esnot_activeExpired - Lifetime
- 2004-01-12CACA002455097Apatent/CA2455097C/ennot_activeExpired - Fee Related
- 2004-07-27USUS10/900,447patent/US7235675B2/ennot_activeExpired - Fee Related
2006
- 2006-12-06JPJP2006329870Apatent/JP4648891B2/janot_activeExpired - Fee Related
2007
- 2007-02-09USUS11/673,180patent/US7476727B2/ennot_activeExpired - Fee Related

Also Published As

Publication number	Publication date
EP1441224B1 (de)	2011-03-02
US20030207431A1 (en)	2003-11-06
JP4648891B2 (ja)	2011-03-09
CA2455097A1 (en)	2004-07-14
CA2455097C (en)	2009-08-25
US7476727B2 (en)	2009-01-13
ES2360699T3 (es)	2011-06-08
EP1441224A2 (de)	2004-07-28
JP2007126466A (ja)	2007-05-24
JP4184986B2 (ja)	2008-11-19
US20050009076A1 (en)	2005-01-13
EP1441224A3 (de)	2005-05-25
DE602004031571D1 (de)	2011-04-14
US20070142631A1 (en)	2007-06-21
JP2004239894A (ja)	2004-08-26
US6811998B2 (en)	2004-11-02
US7235675B2 (en)	2007-06-26

Publication	Publication Date	Title
ATE384952T1 (de)	2008-02-15	Enzymhemmungsimmunverfahren
BR0116719A (pt)	2005-04-12	Biossensores tendo aplicação de amostra aperfeiçoada
WO2004113912A8 (en)	2005-03-10	System and method for determining a temperature during analysis of biological fluid
SE0000538D0 (sv)	2000-02-18	Methods and kits for proximity probing
ATE289685T1 (de)	2005-03-15	Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
ATE509119T1 (de)	2011-05-15	Verfahren zum testen von glykosyliertem protein
CY1107490T1 (el)	2013-03-13	Μεθοδος για την ταυτοποιηση δειγματος σε θηλαστικα καθως και κιτ για την εκτελεση αυτης της μεθοδου
ATE356832T1 (de)	2007-04-15	Zusammensetzungen und verfahren zum nachweis vom apo-b48 und apo-b100
DE602004021281D1 (de)	2009-07-09	Kolorimetrische substrate, kolorimetrische sensoren und verwendungsverfahren
WO2003023051A3 (en)	2003-10-09	Lateral flow test format for enzyme assays
DE60029413D1 (de)	2006-08-31	Enzymatische messung von mycophenolsäure
KR100711046B1 (ko)	2007-04-24	대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
WO2005040759A3 (en)	2006-12-14	Apparatus and methods for detecting target analyte
DK1557473T3 (da)	2009-05-04	Reagenssammensætning til at skelne beta-lactamaser, kit og fremgangsmåde dermed
DE60310012D1 (de)	2007-01-11	Verfahren, Assay und Kit zur Quantifizierung von HIV-Proteasehemmer
ATE500505T1 (de)	2011-03-15	Enzymhemmungsimmunverfahren
DE50110174D1 (de)	2006-07-27	Verfahren und testkit zum nachweis von analyten in einer probe
DE602004017317D1 (de)	2008-12-04	Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
ATE368222T1 (de)	2007-08-15	Entglykosilierte enzymen für konjugaten
EP1342791A3 (de)	2004-03-03	Reagenzien, Methode und Apparat zur Messung von Amylase Aktivität
ATE383418T1 (de)	2008-01-15	Verfahren und zusammensetzungen zur bestimmung glycierter proteine
ATE397674T1 (de)	2008-06-15	Analytische methode und testkit
DE602005013430D1 (de)	2009-04-30	Verwendung von asc als marker für kolorektalkarzinome
EP1636587A4 (de)	2006-07-12	Einen für menschliches protoonkogenes protein spezifischen antikörper enthaltender diagnostischer kit für leberzirrhose
EP1342790A3 (de)	2004-03-03	Reagenzien und Methode zur Messung von Amylase Aktivität

Legal Events

Date	Code	Title	Description
2011-11-15	UEP	Publication of translation of european patent specification	Ref document number:1441224 Country of ref document:EP

Date

Code

Title

Description

2011-11-15

UEP

Publication of translation of european patent specification

Ref document number:1441224

Country of ref document:EP

Movatterモバイル変換